Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 21, Issue 1

January-February 2024

In this Issue

Article
Feature
President’s Column

Article

Sending the Right Message: Optimizing Cytokine-receptor Signaling for Therapeutic Impact

Camelia Benlabiod, PhD,Bethan Psaila, MD, PhD

View Articletitled, Sending the Right Message: Optimizing Cytokine-receptor Signaling for Therapeutic Impact

Sickle Cell Disease in 2023: Laying the Foundation for Future Breakthroughs

Samuel Wilson, MD, MSCR

View Articletitled, Sickle Cell Disease in 2023: Laying the Foundation for Future Breakthroughs

ASH Grassroots Network Lunch Emphasizes Advocacy Aimed at Improving Health Outcomes

View Articletitled, ASH Grassroots Network Lunch Emphasizes Advocacy Aimed at Improving Health Outcomes

The Advent of Bispecific Antibodies for Large B-cell Lymphomas

John H. Baird, MD,Alex F. Herrera, MD

View Articletitled, The Advent of Bispecific Antibodies for Large B-cell Lymphomas

The Holy Grail of Second Complete Remission in Relapsed Pediatric T-acute Lymphoblastic Leukemia

Sarah K. Tasian, MD

View Articletitled, The Holy Grail of Second Complete Remission in Relapsed Pediatric T-acute Lymphoblastic Leukemia

The Year of the Bispecific

Saad Z. Usmani, MD, MBA

View Articletitled, The Year of the Bispecific

Toward Equity in Access for ALL

Lori Muffly, MD, MS

View Articletitled, Toward Equity in Access for ALL

Pola-R-CHP: A Dramatic Shift in the Frontline Treatment Paradigm for Diffuse Large B-cell Lymphoma, or a Small Step Forward?

Neha Akkad, MD,Loretta J. Nastoupil, MD

View Articletitled, Pola-R-CHP: A Dramatic Shift in the Frontline Treatment Paradigm for Diffuse Large B-cell Lymphoma, or a Small Step Forward?

Redefining Cancer Battlefields: Novel CAR T-cell Therapies in Solid Tumor Warfare

Albert C. Yeh, MD,Kate A. Markey, MBBS, PhD

View Articletitled, Redefining Cancer Battlefields: Novel CAR T-cell Therapies in Solid Tumor Warfare

Ironing Out Heart Failure: Clarifying the Role of Intravenous Iron Therapy

Michael Scott, MD

View Articletitled, Ironing Out Heart Failure: Clarifying the Role of Intravenous Iron Therapy

Calibrating Personalized Risk in Patients With Clonal Hematopoiesis

Robert P. Hasserjian, MD

View Articletitled, Calibrating Personalized Risk in Patients With Clonal Hematopoiesis

Feature

Disabilities and Hematology: Opportunities for Enrichment

Georgia Vogelsang, MD,Brooke Sadler, PhD,Representing the ASH DEI Programs Subcommittee

View Articletitled, Disabilities and Hematology: Opportunities for Enrichment

Don’t You Forget About Me: #ASH23

Natasha Szuber, MD,Juliana Perez Botero, MD

View Articletitled, Don’t You Forget About Me: #ASH23

Technology Spotlight
Advances in Proteomic Technologies and Their Applications in Hematology

Kiran K. Mangalaparthi, PhD,Akhilesh Pandey, MD, PhD

View Articletitled, Technology Spotlight Advances in Proteomic Technologies and Their Applications in Hematology

Not So Benign
Antiphospholipid Antibody Syndrome: Clots, Complement, and Catastrophe!

Gloria F. Gerber, MD,Shruti Chaturvedi, MBBS, MS

View Articletitled, Not So Benign Antiphospholipid Antibody Syndrome: Clots, Complement, and Catastrophe!

President’s Column

A Red Cell Is More Than a Sack of Hemoglobin: My 50-year Journey With ASH

Mohandas Narla, DSc

View Articletitled, A Red Cell Is More Than a Sack of Hemoglobin: My 50-year Journey With ASH

Cover Image

Cover Image

All Issues

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Sequencing of Therapy Matters in the Era of Autologous Chimeric Antigen Receptor T-cell Therapy

Restoring T-cell Cytotoxicity To Correct Familial Hemophagocytic Lymphohistiocytosis

Not So Benign
This Is Not Your Father’s Thrombotic Thrombocytopenic Purpura

Perspective
Procedure Skills in Hematology Training: Lost Cause or Worth Fighting For?

ASH Committees Visit Capitol Hill in Support of Funding

Table of Contents

Article

Sending the Right Message: Optimizing Cytokine-receptor Signaling for Therapeutic Impact

Sickle Cell Disease in 2023: Laying the Foundation for Future Breakthroughs

ASH Grassroots Network Lunch Emphasizes Advocacy Aimed at Improving Health Outcomes

The Advent of Bispecific Antibodies for Large B-cell Lymphomas

The Holy Grail of Second Complete Remission in Relapsed Pediatric T-acute Lymphoblastic Leukemia

The Year of the Bispecific

Toward Equity in Access for ALL

Pola-R-CHP: A Dramatic Shift in the Frontline Treatment Paradigm for Diffuse Large B-cell Lymphoma, or a Small Step Forward?

Redefining Cancer Battlefields: Novel CAR T-cell Therapies in Solid Tumor Warfare

Ironing Out Heart Failure: Clarifying the Role of Intravenous Iron Therapy

Calibrating Personalized Risk in Patients With Clonal Hematopoiesis

Feature

Disabilities and Hematology: Opportunities for Enrichment

Don’t You Forget About Me: #ASH23

Technology Spotlight
Advances in Proteomic Technologies and Their Applications in Hematology

Not So Benign
Antiphospholipid Antibody Syndrome: Clots, Complement, and Catastrophe!

President’s Column

A Red Cell Is More Than a Sack of Hemoglobin: My 50-year Journey With ASH

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Article

Feature

President’s Column

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only